References

  1. Uni0ted Nations Assembly. Declaration of Commitment on HIV/AIDS: Five Years Later. Report of the Secretary-General. 60th Session.

  2. Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004; 18(6):887-895. This article on PubMed

  3. Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001; 358(9279):404-409. This article on PubMed

  4. Laurent C, Diakhate N, Gueye NF, Toure MA, Sow PS, Faye MA, Gueye M, Laniece I, Toure Kane C, Liegeois F, Vergne L, Mboup S, Badiane S, Ndoye I, Delaporte E. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002; 16(10):1363-1370. This article on PubMed

  5. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright PF, Gulick R, Johnson WD Jr, Pape JW, Fitzgerald DW. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005; 353(22):2325-2334. This article on PubMed

  6. Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J, Yiannoutsos CT, Musick B, Einterz R, Fife KH, Tierney WM. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006; 20(1):41-48. This article on PubMed

  7. Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ. Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med. 2006; 3(1):e4. This article on PubMed

  8. Bautista SA. Costing of HIV/AIDS treatment in Mexico. Bethesda, MD, Partners for Health Reform-plus Project; 2003.

  9. Harling G, Wood R. The Evolving Cost of HIV in South Africa: Changes in Health Care Cost with Duration on Antiretroviral Therapy for Public Sector Patients. J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):348-54. This article on PubMed

  10. Garratini L, Tediosi F, Di Cintio E, Yin D, Parazzini F, Gruppo di Studio ARCA (AIDS Resources and Costs Analysis). Resource utilization and hospital cost of HIV/AIDS care in Italy in the area of highly active antiretroviral therapy. AIDS Care. 2001 Dec;13(6):733-41. This article on PubMed

  11. Merito M, Bonaccorsi A, Pammolli F, Riccaboni M, Baio G, Arici C, D’Arminio Monforted A, Pezzottie P, Corsinif D, Tramaring A, Caudah R, for the I CO N A Study Group. Economic evaluation of HIV treatments: the I CO N A Cohort Study. Health policy. 2005; 74:304-313. This article on PubMed

  12. Julio Lopez-Bastida, Juan Oliva-Moreno, Lilisbeth Perestelo-Perez and Pedro Serrano-Aguilar. The economic costs and health related quality of life of people with HIV/AIDS in the Canary Islands, Spain. BMC Health Services Research. 2009; 9:55. This article on PubMed

  13. Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A, Jie Y, Wu G, Philips M, Hu Y, Saranchuk P. Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?. AIDS Care. 2008 Sep;20(8):984-94. This article on PubMed

  14. Obinna Onwujekwe, Nkem Dikec, Chinwe Chukwukad, Benjamin Uzochukwube, Cajetan Onyedumd, Chima Onokaabe, Hyacinth Ichokuf. Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria.Health Policy. 2009 May;90(2-3):223-9. This article on PubMed

  15. Kombe G. The human and financial resource requirements for scaling up HIV/AIDS services in Ethiopia. Bethesda, MD, Partners for Health Reform-plus, Abt Associates; 2005.

  16. Kombe G, Galaty D, Nwagbara C. Scaling up antiretroviral treatment in the public sector in Nigeria. A comprehensive analysis of resource requirements. Bethesda, MD, Partners for Health Reform-plus, Abt Associates; 2004.

  17. Kombe G, Smith O. The costs of anti-retroviral treatment in Zambia. Bethesda, MD, Partners for Health Reform-Plus, Abt Associates; 2003.

  18. Serena P Koenig, Cynthia Riviere, Paul Leger, Patrice Severe, Sidney Atwood, Daniel W Fitzgerald, Jean W Pape, and Bruce R Schackman. The cost of antiretroviral therapy in Haiti. Cost Effectiveness and Resource Allocation. 2008 Feb 14;6:3.

  19. Flessa S, Marsc all P. Socio-economic impact of antiviral intervention. Handb Exp Pharmacol. 2009 ;( 189):347-74. This article on PubMed

  20. Moreno JO, Corugedo I, Del Llano J, Roa C, Hidalgo A. International Conference on AIDS Indirect costs in HIV/AIDS ambulatory patients in Spain: A pilot study. Int Conf AIDS. 2002 Jul 7-12.

  21. National Prospective Monitoring System - IV Health-Economics Collaboration, Chelsea & Westminster Hospital Trust, London, United Kingdom. Available online 27 April 2001. Accessed 10 September 2009.

  22. Educational Research Network for West and Central Africa. Research on anti-retroviral treatment (ART) in Ghana. News Letter. Wednesday 5 December 2007.

  23. UN Integrated Regional Information Networks, Ghana. Increase in HIV/Aids Treatment and Care Centres. Main News. Sudan Division- an Independent daily

  24. The Antiretroviral Clinic. Kintampo Municipal Hospital, Ghana 2009.

  25. National Health Insurance Authority, Ghana. 2008.

  26. Max W, Rice D, Mackenzie E. The life time cost of injury. Inquiry. 1990; 27:332-343. This article on PubMed

  27. Levy A, James D, Johnston K, Hogg R, Harrigan P, Harrigan B, Sobolev B, Montaner J. The direct costs of HIV/AIDS care. Lancet Infectious Diseases. 2006; 6(3): 171-177. This article on PubMed